MET.NYSEMetlife INC

13F-HR: MetLife Discloses Q3 2025 Equity Holdings

Sentiment:

Institutional Holdings Report


MetLife Inc. filed its Q3 2025 13F-HR report, revealing $11.13 million in equity holdings across six ETFs, primarily focused on international and broad market indices.

Summary

  • MetLife Inc. filed a Form 13F-HR for the calendar quarter ended September 30, 2025.
  • The report is a 13F Combination Report, indicating that a portion of holdings are reported in this document, while other portions are reported by affiliated managers.
  • The total market value of the reported Section 13(f) securities is $11,126,208.
  • The filing lists 6 distinct equity positions, all of which are Exchange Traded Funds (ETFs).
  • Key holdings include SPDR S&P ETF Trust valued at $4,384,650, iShares MSCI Chile ETF Inc at $2,711,429, and iShares Latin America ETF Trust at $2,121,638.
  • Investment discretion for all reported holdings is defined (DFND), with sole voting authority exercised over all shares.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of equity holdings by an institutional investment manager, providing a factual snapshot of its reported portfolio without indicating positive or negative operational performance or strategic shifts for MetLife Inc. itself.

Positives

  • Timely disclosure of institutional investment manager's equity holdings as required by SEC regulations.
  • The reported portfolio demonstrates diversified exposure across various international and broad market ETFs.

Negatives

  • No specific negatives are inherent in a standard 13F filing, as it is a disclosure of positions rather than operational results or challenges for the reporting entity.

Risks

  • No specific risks related to MetLife's operations or future outlook are detailed in this holdings report. The inherent risks are those associated with the market performance of the disclosed ETF holdings, including geographic and sector-specific market fluctuations.

Future Outlook

NA

Management Comments

  • MetLife Inc. disclaims investment discretion over Section 13(f) securities positions where its investment operating subsidiaries exercise such discretion, but reports the information on behalf of all such subsidiaries due to its ownership interest.

Industry Context

This filing is a routine quarterly disclosure for large institutional investment managers like MetLife, providing transparency into a portion of their equity holdings. It reflects MetLife's investment management arm's allocation to various Exchange Traded Funds (ETFs), with a notable focus on international and broad market exposure. Such disclosures are standard practice for major insurance companies and asset managers, which typically manage vast investment portfolios.

Comparison to Industry Standards

  • MetLife's reported holdings of $11.13 million in this specific 13F filing represent a fraction of its overall investment portfolio, which for a company of its scale typically runs into hundreds of billions of dollars.
  • The allocation to broad market and international ETFs (Europe, Latin America, Chile, Japan, Pacific ex Japan, S&P) is a common strategy for institutional investors seeking diversified exposure, liquidity, and passive management for certain segments of their portfolios.
  • Comparable large institutional investors and insurance companies, such as Prudential Financial or AIG, also file 13F reports, often demonstrating diverse holdings across various asset classes, including significant ETF positions for broad market access and risk management.

Stakeholder Impact

  • Shareholders: Provides transparency into a portion of MetLife's investment portfolio, offering insight into its investment strategy and asset allocation through its subsidiaries.
  • Regulatory Authorities: Fulfills SEC reporting requirements under Section 13(f) of the Securities Exchange Act of 1934, ensuring compliance and market transparency.

Next Steps

  • MetLife Inc. will continue to file Form 13F-HR reports quarterly to disclose its reportable equity holdings as mandated by the SEC.

Key Dates

DateDescription
09-30-2025End of the calendar quarter for which the report is filed.
11-10-2025Date the report was signed by John McCallion, EVP, CFO and Head of MetLife Investment Management.

Keywords

MetLife, 13F, SEC filing, equity holdings, institutional investor, ETF, investment portfolio, Q3 2025, asset management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.